Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.

The following is a summary of “Evaluating lipid-lowering drug targets for full-course diabetic retinopathy,” published in the ...

Surrogate measures of insulin resistance, based on the triglyceride-glucose index, can be used to predict the development of ...

Regeneron Pharmaceuticals Inc. (REGN) announced positive three-year (156-week) results for EYLEA HD (aflibercept) Injection 8 mg in ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.